Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-serine for Cognitive Dysfunction in Schizophrenia
NCT00817336Phase 2Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Jun 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-serine in schizophrenia, schizoaffective disorder, sponsored by Nathan S. Kline Institute for Psychiatric Research. Started Jun 2009; status: completed.
02
Drugs
d-serine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00817336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817336.